Aditx Therapeutics Inc (ADTX) Form 4 Filing on June 12

AI Summary

Aditx Therapeutics Inc (ADTX) submitted a Form 4 with the SEC on June 12. This filing typically includes information about insider trading, including stock purchases or sales by executives. The data provided in the Form 4 is crucial for investors to assess insider confidence in the company's future. Without specific transaction details reported in this case, it's important for stakeholders to review the filing for any indications of management's views on stock valuation and future prospects.